RXI has gone through P1 and near end of P2 in under two years. Not sure how many are aware just how fast that is. Attributable to quickness of skin healing along with readily visible results. Quite a different scenario from most drug trials. Most would have taken 3-5 times as long.
Credit to Cauwenbergh who chose to take on the task of heading RXI, knowing the nearer term potential. (mu guess here). We have yet to get updated on the scope of the platform this could produce. News will be soon. Just my thought this afternoon.....GLTA
Think I may be mistaken and caught wrong screen, but I do see 16.12m on both Ihub and Finviz? Sorry for the false alarm gents.............GL
I had a doctor tell me I had six months to live. I told him I could not pay his bill right away. He gave me another six months.................GLTA
just some longs ragging on the bashers.. its only a message board. Entertainment mostly, not much to do about anything really. The company is all that matters ................GL
For a long period of time, and that they even interbred. Brings avi.moron to mind, does it not?................GLTA
yes, it is his full time job. He is a stock bashing lackey for his boss. Not very good at his job, and based on his comments, I'd say he's definitely a dummy..................GLTA
Neither is he concerned about retail investors who cannot endure the challenge of patience. His job is not holding the hands of his investors, rather it is to create value for them and his company.
Personally, I like his style. I like his track record, and I like the company's potential............GLTA
The drops create more selling, but weak retail judging by volume. mm march down again, same pattern repeating. the big question, where are the buyers to offset it?
Summer hiatus, still to obscure, too cheap 35M m/cap, waiting on news? I don't know.
Just know fundamentals not the cause IMO, I remain vry bullish ............GL
If they have an update by then, more likely they will put it out just before a conference, as this was their timing in the past, often the day before.
Separating PR from presentation more effective IMO. Anyway, from my experience following RXI this was the norm...........GLTA
Worth the wait IMO. Two plus years of good DD by many experienced contributors. Not to lose sight its still P2. But with positive news, RXI will get the attention that has alluded this tiny company. Too much potential for a $35M m/cap company the way I see it.
Cauwenbergh is a tried and proven CEO. My bet is on him. No substitute for top management......GLTA
See how afraid these jerks of my posts? just follow this thread. Too easy to control these idiots...GLTA
Good point 1961..Just to add, RXI no longer a one trick pony, far from it with the progress made this past year. In addition to P2 scarring trials, I expect the delivery tech, sdrx-RNA will be the "self delivery" method for a host of RNAi compounds that to date have had difficulty being delivered effectively to their intended target. Licensing and partnering in the works.
RXI now a "platform technology" biotech. applications for their science to cover a very wide range of applications, as we recently were informed of, PVR, macular deg, liver fibrosis, as example.
I scratch my head as to why the m/cap is at $35M. We are either extremely lucky or there is something we don't know. But, what don't we know?.................GLTA
I block them. Just enjoy exposing them before the board on occasion for the benefit of a few who may fall prey to their BS.............GLTA
being paid to work overtime now. for the sole reason that their bosses want cheap shares of RXI. The try scare you, you sell your shares, the price goes down, then the buy them on the cheap.
It is as simple as that. Those that are not hep to their methods are losers of money if they fall prey to their scare tactics and misinformation.
They are very low forms of life.........................GLTA